All filters
Abstracts
Epidemiological distribution of SARS-CoV-2 lineages by spike region genomic analysis: January 2021-January 2022 variants distribution in Tuscany Nord- Ovest area
M. Vatteroni Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
A case of re-infection with a different SARS-CoV-2 lineage in an unvaccinated child
M. Vatteroni Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
26 Study on the continuity of Tuberculosis (TB) care services in a COVID-19 context, Senegal, 2021
I. Keita Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Situation with COVID-19 among HIV-infected patients in Armenia
N.Sargsyants Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
28 Study on the continuity of HIV care services in a COVID-19 context, Senegal, 2021
I. Mamby Keita Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Prevalence of coranavirus disease-2019(COVID-19) in a testing centre in Anambra state, Nigeria
S. Kalu Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
International Transmission Clusters of Acute Hepatitis C Virus Among Men Who Have Sex With Men in the Netherlands. A phylogenetic analysis.
D. Vijver Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Epidemiological and clinical features of SARS-CoV-2 variants circulating between April- December 2021 in Italy
C. Ventura Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
HIV-1 Molecular Phylogenies Characterized by Near Full- Length Genome Sequencing
C. Topcu Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Genome characterization of HIV- 2 biological clones isolated from long term non-progressors (LTNP) vs patients with progressive infection
R. Gruters Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Epidemiology of HIV -1 recombinant 2010-2018. forms in Israel
 T. Wagner Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Identification of a New HIV-1 Circulating Recombinant Form CRF91_cpx in Cyprus
C. Topcu Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Hepatitis B Virus Sub-genotype A1 Evolutionary Dynamics in Botswana
D. Ditshwanelo Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
The evaluation of a 5-plex “rainbow” digital PCR assays to measure intact HIV-1 proviral DNA
M. Delporte Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Patterns of PrEP use among first- time users of oral HIV pre- exposure prophylaxis in the general population in Eswatini
S. Mukherjee Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Quality of life of injecting drug users living with HIV in Minsk, Belarus
M. Shylava Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Evolutionary dynamics of the recently identified HIV subtype a outbreak in Montenegro explored through advanced phylodynamic approach
S. Dragas Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Update on transmitted drug resistance in newly diagnosed HIV patients during the period from 2019 to 2020
 L. Viñuela Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Archived HIV-1 drug resistance is driven by NNRTI-mutations and associated with viral replication among adolescents in Cameroon
 A. Ka'e Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Increasing protease inhibitor resistance mutations among HIV-infected children and adolescents with virologic failure
E. Mgeyi Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Detection of mutations associated with antiretroviral drug resistance from HIV proviral DNA in patients with low-level viremias
P. Ferrer Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Clonal Case Assessments for Participants Failing with Emergent Integrase Resistance in the DAWNING Second Line Study
M. Underwood Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
K156N integrase substitution in combination with 3’PPT resistance mutations against dolutegravir
R. Gruters Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Long-term Efficacy, Safety, and Durability of Ibalizumab-based Regimens in Subgroup of TMB- 202 Participants
H. Jullien Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022